Ang2 mRNA expression has been reported to predict poor prognosis in breast cancer [28], and high circulating Ang2 levels were reported to predict unfavourable outcome in metastatic colorectal carcinoma [29], mRCC [30] and melanoma [31]. This evidence concerns the gene ANGPT2 and breast carcinoma.